HK1062170A1 - Process for the preparation of 1,3-substituted in denes and aryl-fused azapolycyclic compounds - Google Patents

Process for the preparation of 1,3-substituted in denes and aryl-fused azapolycyclic compounds

Info

Publication number
HK1062170A1
HK1062170A1 HK04105132A HK04105132A HK1062170A1 HK 1062170 A1 HK1062170 A1 HK 1062170A1 HK 04105132 A HK04105132 A HK 04105132A HK 04105132 A HK04105132 A HK 04105132A HK 1062170 A1 HK1062170 A1 HK 1062170A1
Authority
HK
Hong Kong
Prior art keywords
denes
aryl
substituted
preparation
fused azapolycyclic
Prior art date
Application number
HK04105132A
Other languages
English (en)
Inventor
Robert Alan Singer
Jason Daniel Mckinley
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of HK1062170A1 publication Critical patent/HK1062170A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C317/00—Sulfones; Sulfoxides
    • C07C317/44—Sulfones; Sulfoxides having sulfone or sulfoxide groups and carboxyl groups bound to the same carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C253/00—Preparation of carboxylic acid nitriles
    • C07C253/30—Preparation of carboxylic acid nitriles by reactions not involving the formation of cyano groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C255/00—Carboxylic acid nitriles
    • C07C255/45—Carboxylic acid nitriles having cyano groups bound to carbon atoms of rings other than six-membered aromatic rings
    • C07C255/47—Carboxylic acid nitriles having cyano groups bound to carbon atoms of rings other than six-membered aromatic rings to carbon atoms of rings being part of condensed ring systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/08—One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Addiction (AREA)
  • Psychiatry (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
  • Psychology (AREA)
  • Diabetes (AREA)
  • Child & Adolescent Psychology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Vascular Medicine (AREA)
  • Anesthesiology (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
HK04105132A 2001-04-20 2004-07-14 Process for the preparation of 1,3-substituted in denes and aryl-fused azapolycyclic compounds HK1062170A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US28513101P 2001-04-20 2001-04-20
PCT/IB2002/000660 WO2002085843A2 (en) 2001-04-20 2002-03-04 Process for the preparation of 1,3-substituted indenes and aryl-fused azapolycyclic compounds

Publications (1)

Publication Number Publication Date
HK1062170A1 true HK1062170A1 (en) 2004-10-21

Family

ID=23092860

Family Applications (1)

Application Number Title Priority Date Filing Date
HK04105132A HK1062170A1 (en) 2001-04-20 2004-07-14 Process for the preparation of 1,3-substituted in denes and aryl-fused azapolycyclic compounds

Country Status (25)

Country Link
US (2) US7091372B2 (xx)
EP (1) EP1383733B1 (xx)
JP (1) JP2004527545A (xx)
KR (1) KR100551183B1 (xx)
CN (1) CN1321107C (xx)
AR (2) AR035957A1 (xx)
AT (1) ATE388135T1 (xx)
AU (1) AU2002234836B2 (xx)
BR (1) BR0208992A (xx)
CA (1) CA2443946A1 (xx)
CZ (1) CZ20032814A3 (xx)
DE (1) DE60225433T2 (xx)
DK (1) DK1383733T3 (xx)
ES (1) ES2300430T3 (xx)
HK (1) HK1062170A1 (xx)
HU (1) HUP0303811A3 (xx)
IL (1) IL157881A0 (xx)
MX (1) MXPA03009527A (xx)
PL (1) PL366657A1 (xx)
PT (1) PT1383733E (xx)
RU (1) RU2282619C9 (xx)
TW (1) TWI244472B (xx)
WO (1) WO2002085843A2 (xx)
YU (1) YU78303A (xx)
ZA (1) ZA200307205B (xx)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003044877A2 (en) * 2001-11-16 2003-05-30 Cdt Oxford Limited Light emitting device and compounds for use therein
CN1714075A (zh) * 2002-11-25 2005-12-28 辉瑞产品公司 1,3－取代的茚类的改进制备方法
KR20070087258A (ko) * 2003-01-15 2007-08-27 화이자 프로덕츠 인크. 아릴 융합된 폴리시클릭 락탐의 제조 방법
EP1638971B1 (en) * 2003-06-04 2008-08-20 Pfizer Products Inc. Preparation of substituted quinoxalines from the dianiline with 2,3-dihydroxy-1,4-dioxane
WO2005007630A2 (en) * 2003-07-21 2005-01-27 Pfizer Products Inc. Aryl fused azapolycyclic compounds
ES2343141T3 (es) * 2005-11-16 2010-07-23 F. Hoffmann-La Roche Ag Nuevo procedimiento para la preparacion de thoc.
DE102006024903A1 (de) * 2006-05-24 2007-11-29 Basf Ag Verfahren zur Vermeidung von Fumarsäureablagerungen bei der Herstellung von Maleinsäureanhydrid
ES2374337T3 (es) 2007-05-16 2012-02-15 Nycomed Gmbh Derivados de pirazolona como inhibidores de pde4.
EP2019107A1 (en) 2007-07-26 2009-01-28 Dynamit Nobel GmbH Explosivstoff- und Systemtechnik Use of phosphonium salts in coupling reactions and process for their manufacture
WO2009065872A2 (en) * 2007-11-20 2009-05-28 Medichem, S.A. Improved processes for the synthesis of varenicline l-tartrate
WO2009101185A2 (en) * 2008-02-15 2009-08-20 Medichem, S.A. A NEW POLYMORPHIC FORM OF A PYRAZINO[2,3-h][3] BENZAZEPINE DERIVATIVE
US8039620B2 (en) 2008-05-22 2011-10-18 Teva Pharmaceutical Industries Ltd. Varenicline tosylate, an intermediate in the preparation process of varenicline L-tartrate
US20090318695A1 (en) * 2008-06-19 2009-12-24 Vinod Kumar Kansal Processes for the preparation of varenicline and intermediates thereof
WO2010005643A1 (en) * 2008-07-10 2010-01-14 Teva Pharmaceutical Industries Ltd. Processes for purifying varenicline l-tartrate salt and preparing crystalline forms of varenicline l-tartrate salt
WO2010151524A1 (en) 2009-06-22 2010-12-29 Teva Pharmaceutical Industries Ltd Solid states forms of varenicline salts and processes for preparation thereof
US20120004239A1 (en) 2010-06-11 2012-01-05 Medichem, S.A. Process for Preparing Quinoxaline Derivatives
KR101603427B1 (ko) * 2014-08-14 2016-03-15 영남대학교 산학협력단 케스케이드 반응을 통한 인덴 유도체의 효율적 합성방법
CN104478803A (zh) * 2014-12-19 2015-04-01 连云港恒运医药科技有限公司 伐尼克兰中间体及其硝基还原杂质的制备方法
EP3334703A4 (en) * 2015-08-14 2019-07-03 Boulos & Cooper Pharmaceuticals PTY Ltd SYNTHESIS OF ARYLIC COMPOUNDS
CA3030147A1 (en) 2016-07-07 2018-01-11 Howard Hughes Medical Institute Modified ligand-gated ion channels and methods of use
US10961296B2 (en) * 2017-11-10 2021-03-30 Howard Hughes Medical Institute Modified ligand-gated ion channels and methods of use
CN111995519B (zh) * 2020-09-26 2022-08-26 安徽金禾实业股份有限公司 一种3-甲氧基丙烯酸甲酯的制备方法
CN115322105A (zh) * 2021-05-11 2022-11-11 江苏润安制药有限公司 一种合成艾拉莫德关键中间体的方法

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5479598A (en) * 1992-10-23 1995-12-26 International Business Machines Corporation Compact graphical parallel program user output interface controlled directly by the parallel computer program
DE69409445D1 (de) * 1993-07-27 1998-05-14 Ibm Prozessüberwachung in einem Mehrfachverarbeitungsanbieter
US6289368B1 (en) * 1995-12-27 2001-09-11 First Data Corporation Method and apparatus for indicating the status of one or more computer processes
US5928323A (en) * 1996-05-30 1999-07-27 Sun Microsystems, Inc. Apparatus and method for dynamically generating information with server-side software objects
FR2751448B1 (fr) * 1996-07-17 1999-01-15 Bull Sa Procede de surveillance en temps reel d'un systeme informatique pour son administration et l'aide a sa maintenance en phase d'exploitation
US6112194A (en) * 1997-07-21 2000-08-29 International Business Machines Corporation Method, apparatus and computer program product for data mining having user feedback mechanism for monitoring performance of mining tasks
US6119165A (en) * 1997-11-17 2000-09-12 Trend Micro, Inc. Controlled distribution of application programs in a computer network
US6100887A (en) * 1997-12-05 2000-08-08 At&T Corporation Reusable reversible progress indicator software component for a graphical user interface
DK1044189T4 (en) * 1997-12-31 2015-03-30 Pfizer Prod Inc Aryl-fused fused azapolycyclic connections
US6605610B1 (en) * 1997-12-31 2003-08-12 Pfizer Inc Aryl fused azapolycyclic compounds
US6151357A (en) * 1998-01-16 2000-11-21 Aspect Communications Corporation Method and apparatus for displaying a visual indication of a transmission status
US6108003A (en) * 1998-03-18 2000-08-22 International Business Machines Corporation Maintaining visibility and status indication of docked applications and application bars
CN1144787C (zh) * 1998-04-29 2004-04-07 辉瑞产品公司 芳基稠合氮杂多元环化合物
FR2788982B1 (fr) * 1999-02-02 2002-08-02 Synthelabo Compositions pharmaceutiques contenant de la nicotine et leur application dans le sevrage tabagique
AU5667100A (en) * 1999-07-02 2001-01-22 Prescient Neuropharma Inc. Novel aminoindanes
IL137937A0 (en) * 1999-08-27 2001-10-31 Pfizer Prod Inc A pharmaceutical composition for the prevention and treatment of nicotine addiction in a mammal
US20010036943A1 (en) * 2000-04-07 2001-11-01 Coe Jotham W. Pharmaceutical composition for treatment of acute, chronic pain and/or neuropathic pain and migraines
US20010036949A1 (en) * 2000-05-09 2001-11-01 Coe Jotham Wadsworth Pharmaceutical composition and method of treatment of diseases of cognitive dysfunction in a mammal
US20020010192A1 (en) * 2000-06-02 2002-01-24 Coe Jotham Wadsworth Pharmaceutical composition for the treatment of obesity or to facilitate or promote weight loss
US20020016334A1 (en) * 2000-07-31 2002-02-07 Coe Jotham Wadsworth Pharmaceutical composition for the treatment of attention deficit hyperactivity disorder (ADHD)

Also Published As

Publication number Publication date
EP1383733A2 (en) 2004-01-28
YU78303A (sh) 2006-05-25
IL157881A0 (en) 2004-03-28
HUP0303811A2 (hu) 2004-03-01
TWI244472B (en) 2005-12-01
US20060079707A1 (en) 2006-04-13
ATE388135T1 (de) 2008-03-15
JP2004527545A (ja) 2004-09-09
CA2443946A1 (en) 2002-10-31
US20030060624A1 (en) 2003-03-27
HUP0303811A3 (en) 2008-05-28
CZ20032814A3 (cs) 2004-08-18
US7186870B2 (en) 2007-03-06
EP1383733B1 (en) 2008-03-05
WO2002085843A3 (en) 2003-06-05
US7091372B2 (en) 2006-08-15
AU2002234836B2 (en) 2007-08-23
KR20030092087A (ko) 2003-12-03
AR043636A2 (es) 2005-08-03
PL366657A1 (en) 2005-02-07
ES2300430T3 (es) 2008-06-16
KR100551183B1 (ko) 2006-02-13
DE60225433T2 (de) 2008-06-12
AR035957A1 (es) 2004-07-28
ZA200307205B (en) 2004-09-15
DE60225433D1 (de) 2008-04-17
CN1503781A (zh) 2004-06-09
RU2003130751A (ru) 2005-03-27
MXPA03009527A (es) 2004-02-12
WO2002085843A2 (en) 2002-10-31
PT1383733E (pt) 2008-04-15
RU2282619C9 (ru) 2006-12-20
BR0208992A (pt) 2004-04-27
DK1383733T3 (da) 2008-06-09
CN1321107C (zh) 2007-06-13
RU2282619C2 (ru) 2006-08-27

Similar Documents

Publication Publication Date Title
HK1062170A1 (en) Process for the preparation of 1,3-substituted in denes and aryl-fused azapolycyclic compounds
HUP9900163A3 (en) Process for the preparation of sterol-and stanol-esters, and use thereof
HK1098737A1 (en) Process for the preparation of 1,1,1,3,3-pentafluoro-2-chloropropene and 1,1,1,3,3,3-hexafluoro-2-chloropropane
AU2003233010A8 (en) Process for the preparation of 3,3,4,4-tetrafluoropyrrolidine and derivatives thereof
HUP0102833A3 (en) Cyclosporins, process for preparation thereof and their use
AP2000002010A0 (en) Novel pharmaceutical compositions for treating and saving and the methods for the preparation thereof
PL371122A1 (en) Process for preparing 3,3',5,5',6,6'-hexaalkyl-2,2'-biphenols, 3,3',4,4',5,5'-hexaalkyl-2,2'-biphenols and 3,3',4,4',5,5',6,6'-octaalkyl-2,2'-biphenols
GB0126643D0 (en) Composition and process
EP0990632A4 (en) ADAMANTANEMETHANOL DERIVATIVES AND PROCESS FOR THE PREPARATION THEREOF
IL139023A0 (en) Process for the preparation of 2,3,5-trimethyl-p- benzoquinone
HUP0301725A3 (en) Novel compounds and process
HUP0401577A3 (en) Process for the preparation of 2,4-didezoxyhexoses and 2,4,6-tridezoxyhexoses
HUP0402544A3 (en) Composition for electrolytic solution and process for producing the same
GB9917593D0 (en) Compound, composition, process and use
GB0014580D0 (en) Appatarus and process
HUP0102772A3 (en) Novel compounds derived from alpha-d-xylose, preparation method and therapeutic use
EP1396534A4 (en) PERFUME COMPOSITION AND PROCESS FOR PRODUCING THE SAME
EP1295864A4 (en) PROCESS FOR THE PREPARATION OF 1,5-DIAMINONAPHTHALINES
IL137364A (en) Process for the preparation of 6,6-dimethylhept-1-en-4-yn-3-ol
SG95675A1 (en) Process for the preparation of 2,6-xylenol
HK1041606B (zh) N，n'-羰基雙內酰胺的製備方法
HUP0100584A3 (en) Triazepinones, process for their preparation and their therapeutic application
GB0126647D0 (en) Composition and process
GB0126644D0 (en) Composition and process
GB0126646D0 (en) Composition and process

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20110304